Selegiline Orally Disintegrating Tablets and Cardiac disease
Result of checking the interaction of drug Selegiline Orally Disintegrating Tablets and disease Cardiac disease for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of selegiline has been associated with cardiovascular events such as tachycardia, bradycardia, syncope, hypertension, hypotension, arrhythmias, and aggravation of angina pectoris. Therapy with selegiline should be administered cautiously in patients with cardiac disease.
- "Product Information. Eldepryl (selegiline)." Somerset Pharmaceuticals Inc, Tampa, FL.
- Brodersen P, Philbert A, Gulliksen G, Stigard A "The effect of L-Deprenyl on on-off phenomena in Parkinson's disease." Acta Neurol Scand 71 (1985): 494-7
Generic Name: selegiline
Brand Name: Eldepryl, Zelapar, Emsam
Synonyms: Selegiline